Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02908555 · ClinicalTrials.gov registry record
Sleep, Coping and Executive Functioning in Youth With Type 1 Diabetes
A clinical trial, sponsored by Yale University.
- Completed
- Registry status
- 40
- Enrollment target
NCT02908555 is a clinical trial that has completed, run by Yale University. The registered enrollment target is 40 participants.
The verdict
NCT02908555 has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- 40 participants
- Enrollment target
Study Summary
The purpose of this exploratory study is to evaluate the characteristics of sleep, perceptions of barriers and facilitators to adequate sleep, and the associations among sleep characteristics, executive functioning, coping, adherence, 24-hour glucose levels, and adjustment in adolescents with type 1 diabetes. A mixed methods approach that includes a quantitative component, consisting of actigraphy and sleep diaries, questionnaires, tests of executive function and continuous glucose monitoring (CGM) as well as a narrative qualitative component will be used. Results from this pilot study will be used to provide the effect sizes needed for a larger-scale descriptive study and to establish the need for a possible sleep-promoting intervention for adolescents with type 1 diabetes. This project is consistent with ongoing research focused on developing preventive, behavioral interventions for youth with type 1 diabetes and their families to improve physiological (i.e., glycemic control) and psychological (i.e., quality of life) outcomes. Sleep promotion may become an important component of these interventions. Thus, the following specific aims will be addressed: 1. Describe the objective and subjective characteristics of sleep (duration, continuity, bed time/rise times); sleep quality and sleep habits among adolescents with type 1 diabetes. 2. Explore the relationship between characteristics of self-reported sleep (i.e., habits, duration, daytime sleepiness) and executive function, coping, adherence, and adjustment (i.e., depressive symptoms, quality of life) in adolescents with type 1 diabetes. 3. Explore the relationship of glucose excursions on sleep characteristics and executive functioning. 3\. Conduct a qualitative study using narrative analysis with adolescents to identify perceived barriers, facilitators, and consequences associated with insufficient sleep in adolescents with type 1 diabetes.
Interventions
- OTHER No intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2016-01 |
| Est. Completion | 2018-06-15 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02908555
The ClinicalTrials.gov registry entry for NCT02908555 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which No intervention is the first listed.
NCT02908555 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02908555 about?
NCT02908555 is a clinical study titled "Sleep, Coping and Executive Functioning in Youth With Type 1 Diabetes". The purpose of this exploratory study is to evaluate the characteristics of sleep, perceptions of barriers and facilitators to adequate sleep, and the associations among sleep characteristics, executive functioning, coping, adherence, 24-hour glucose levels, and adjustment in adolescents with type 1...
What is the current status of trial NCT02908555?
This trial is currently completed. The enrollment target is 40 participants. The study started on 2016-01. Estimated completion is 2018-06-15.
What interventions are being tested in trial NCT02908555?
The interventions under investigation include: No intervention (OTHER).
Who is sponsoring clinical trial NCT02908555?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.